Low Incidence Rate of Opportunistic and Viral Infections During Imatinib Treatment in Chronic Myeloid Leukemia Patients in Early and Late Chronic Phase.

BACKGROUND: Imatinib has become first line therapy in chronic myeloid leukemia patients. Little is known about the infective consequences during the treatment with this drug in large series of chronic phase patients. MATERIAL AND METHODS: From January 2001 to September 2006 we treated with imatinib...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Breccia, Massimo, Girmenia, Corrado, Latagliata, Roberto, Loglisci, Giuseppina, Santopietro, Michelina, Federico, Vincenzo, Petrucci, Luigi, Serrao, Alessandra, Salaroli, Adriano, Alimena., Giuliana
Format: Artigo
Sprog:Inglês
Udgivet: Università Cattolica del Sacro Cuore 2011
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3113277/
https://ncbi.nlm.nih.gov/pubmed/21713076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2011.021
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker